,i  #aadth ,,congress  #ast ,session    
,h4 ,r4 #bdba  ,,in ,,the ,,house ,,of  
,,representatives  ,may #ai1 #bjae ,mr4 
,barton introduced the following bill2  
which was referred to the ,committee on 
,energy and ,commerce  ,a ,,bill  ,to   
amend the ,public ,health ,service ,act 
to increase accountability at the       
,national ,institutes of ,health4  #a4  
,increasing accountability at the       
,national ,institutes of ,health  7a7   
,appointment and terms of directors of  
national research institutes and        
national centers ,subsection 7a7 of     
section #dje of the ,public ,health     
,service ,act 7#db ,u4,s4,c4 #bhd7 is   
amended to read as follows3  7a7        
,appointment2 terms  7#a7 ,appointment  
,the ,director of the ,national ,cancer 
,institute shall be appointed by the    
,president and the directors of the     
other national research institutes1 as  
well as the directors of the national   
centers1 shall be appointed by the      
,director of ,,nih4 ,the directors of   

the national research institutes1 as    
well as national centers1 shall report  
directly to the ,director of ,,nih4     
7#b7 ,terms  7,a7 ,in general ,the term 
of office of a director of a national   
research institute or national center   
shall be #e years4  7,b7 ,removal ,the  
director of a national research         
institute or national center may be     
removed from office by the ,director of 
,,nih prior to the expiration of such   
director's #e-year term4  7,c7          
,reappointment ,at the end of the term  
of a director of a national research    
institute or national center1 the       
director may be reappointed4 ,there is  
no limit on the number of terms a       
director may serve4  7,d7 ,vacancies ,if
 the office of a director of a national 
research institute or national center   
becomes vacant before the end of such   
director's term1 the director appointed 
to fill the vacancy shall be appointed  
for a #e-year term starting on the date 
of such appointment4  7,e7 ,transitional

 provision ,each director of a national 
research institute or national center   
serving on the date of enactment of the 
#bast ,century ,cures ,act is deemed to 
be appointed for a #e-year term under   
this subsection starting on such date of
 enactment4  4  7b7 ,compensation to    
consultants or individual scientists    
,section #bjb of the ,departments of    
,labor1 ,health and ,human ,services1   
and ,education1 and ,related ,agencies  
,appropriations ,act1 #aiic 7,public    
,law #ajb-cid2 #db ,u4,s4,c4 #bch;f     
note7 is amended by striking portable   
structures2 and all that follows and    
inserting portable structures44  7c7    
,review of certain awards by directors  
,section #dje7;b7 of the ,public ,health
 ,service ,act 7#db ,u4,s4,c4 #bhd7;b77 
is amended by adding at the end the     
following3  7#c7 ,before an award is    
made by a national research institute or
 by a national center for a grant for a 
research program or project 7commonly   
referred to as an ,r-series grant71     

other than an award constituting a      
noncompeting renewal of such grant1 or a
 noncompeting administrative supplement 
to such grant1 the director of such     
national research institute or national 
center--  7,a7 shall review and approve 
the award2 and  7,b7 shall take into    
consideration--  7i7 the mission of the 
national research institute or national 
center and the scientific priorities    
identified in the strategic plan under  
section #djb7m72 and  7ii7 whether other
 agencies are funding programs or       
projects to accomplish the same goal4  4
  7d7 ,,iom study on duplication in     
,federal biomedical research ,the       
,secretary of ,health and ,human        
,services shall enter into an           
arrangement with the ,institute of      
,medicine of the ,national ,academies   
7or1 if the ,institute declines1 another
 appropriate entity7 under which the    
,institute 7or other appropriate entity7
 not later than #b years after the date 
of enactment of this ,act will-- 7#a7   

complete a study on the extent to which 
biomedical research conducted or        
supported by ,federal agencies is       
duplicative2 and  7#b7 submit a report  
to the ,congress on the results of such 
study1 including recommendations on how 
to prevent such duplication4